Vision Issues Could Raise Odds for Dementia
WEDNESDAY, June 29, 2022 (HealthDay News) — Untreated vision loss may put an older adult at an increased risk for dementia, though it’s not clear why, according to a new study.Researchers found that the likelihood of having some form of cognitive imp…
Learn MoreU.S. Begins Targeted Vaccine Rollout Against Monkeypox
TUESDAY, June 28, 2022 (HealthDay News) — The United States is deploying an enhanced nationwide vaccination strategy to counter the continuing spread of monkeypox, federal public health officials announced at a White House briefing on Tuesday.The U.S…
Learn MoreFDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
TUESDAY, June 28, 2022 (HealthDay News) — A U.S. Food and Drug Administration advisory panel recommended on Tuesday that updated COVID-19 booster shots be used this fall to protect against Omicron and its highly contagious subvariants.Because the vir…
Learn MoreSARS-CoV-2-Linked Hospitalization, ED Encounters Rare After Paxlovid
TUESDAY, June 28, 2022 (HealthDay News) — Hospitalization and emergency department encounters related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occur rarely during the five to 15 days after Paxlovid treatment is dispensed for mi…
Learn MoreVaccines Estimated to Have Prevented 19.8 Million COVID-19 Deaths
TUESDAY, June 28, 2022 (HealthDay News) — During the first year of COVID-19 vaccination, vaccines prevented 19.8 million deaths, using excess death as an estimate of the true extent of the pandemic, according to a study published online June 23 in Th…
Learn MoreUn panel de la FDA sopesará unas dosis de refuerzo mejoradas de Moderna y Pfizer
LUNES, 27 de junio de 2022 (HealthDay News) — Un panel asesor de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. votará el martes sobre si recomendar o no que se utilicen unas dosis de refuerzo de las vacunas contra la COVID-19 actuali…
Learn MoreSome Pharmacies Limiting Morning-After Pill Sales to Avoid Potential Shortage
TUESDAY, June 28, 2022 (HealthDay News) — CVS and Rite Aid are limiting purchases of morning-after pills in the wake of the Supreme Court’s decision to overturn Roe v. Wade.To avoid a shortage, CVS is temporarily restricting purchases of the emergenc…
Learn MoreParticipation in Cardiac Rehabilitation Is Low Overall
TUESDAY, June 28, 2022 (HealthDay News) — Participation in cardiac rehabilitation (CR) is low overall, and lower among Asian, Black, and Hispanic individuals compared with Whites, according to a study published online June 22 in the Journal of the Am…
Learn MoreFacebook, Instagram Remove Posts Offering Abortion Pills
TUESDAY, June 28, 2022 (HealthDay News) — Facebook and Instagram have started taking down posts that offer abortion pills to women who may not be able to get them after the Supreme Court’s reversal of Roe v. Wade. These posts told women how to get ab…
Learn MoreApenas 1 de cada 4 pacientes recibe rehabilitación tras un ataque cardiaco o una cirugía del corazón
LUNES, 27 de junio de 2022 (HealthDay News) — Los programas de ejercicio bajo supervisión médica le hacen mucho bien a los pacientes cardiacos, pero pocas personas de color participan en ellos, sin importar sus ingresos, encuentra una investigación r…
Learn More